Study guide

7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis

Key Takeaways Explain This Topic AI

Transcatheter Aortic Valve Replacement (TAVR) balloon-expandable or self-expanding bioprostheses carry significant risks of conduction system injury—most notably high-degree AV block and new LBBB—due to mechanical compression of the AV node and left bundle branch within the membranous septum, frequently requiring permanent pacemaker implantation.

Paravalvular leak (PVL) post-TAVR results from incomplete sealing between the prosthetic frame and calcified native aortic annulus; it is diagnosed via echocardiography and invasive hemodynamics (low Aortic Regurgitation Index <25) and increases long-term mortality.

Transcatheter Edge-to-Edge Repair (TEER with MitraClip) requires precise transeptal puncture under transesophageal echocardiographic guidance; post-procedure care involves monitoring left atrial pressure (LAP) reduction, checking for residual MR vs stenosis, and monitoring for iatrogenic ASD or pericardial effusion.

Emergency pericardiocentesis under fluoroscopic or echocardiographic guidance relieves cardiac tamponade; post-procedure nursing management requires strict drainage tracking and vigilance for cardiac re-accumulation or post-drainage pulmonary edema.

Post-pericardiocentesis pulmonary edema occurs when rapid evacuation of a large pericardial effusion causes a sudden surge in right ventricular preload and cardiac output that exceeds the stunned left ventricle's pumping capacity, causing acute pulmonary congestion.

Last updated: August 2026

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter Aortic Valve Replacement (TAVR) has revolutionized the management of severe, symptomatic aortic stenosis. The procedure involves percutaneous deployment of a collapsible bioprosthetic aortic valve—either balloon-expandable (e.g., Edwards SAPIEN) or self-expanding (e.g., Medtronic Evolut)—within the diseased native aortic valve under fluoroscopic and echocardiographic guidance.

Vascular Access Routes

Transfemoral (TF) Access: The gold-standard primary approach (>90% of cases). Utilizes large-bore arterial sheaths (14 to 18 Fr) placed in the common femoral artery. Requires adequate luminal diameter (≥ 5.0–5.5 mm), minimal calcification, and absence of severe tortuosity.

Alternative Access Routes: Utilized when femoral arterial anatomy is inadequate due to severe peripheral arterial disease:

Transaxillary / Subclavian Access: Percutaneous or surgical cutdown into the subclavian artery.

Transapical (TA) Access: Surgical mini-thoracotomy with direct puncture of the LV apex (associated with higher morbidity).

Transaortic (TAo) or Transcarotid Access: Surgical access via mini-sternotomy or carotid cutdown.

  • Conduction Complications, Paravalvular Leak & Vascular Access Monitoring
  • Conduction System Injuries & Permanent Pacemaker Risk

The anatomical location of the aortic valve annulus creates an inherent vulnerability: the atrioventricular (AV) node and the bundle of His / left bundle branch traverse the membranous septum directly underneath the native aortic cusps. Radial compression exerted by the expanded bioprosthetic frame causes mechanical trauma, tissue edema, or hematoma formation in the conduction system. Aortic Annulus Frame Radial Expansion ---> Mechanical Trauma to Membranous Septum

└──> AV Node / Left Bundle Branch Compression ---> New LBBB / High-Degree AV Block ---> Permanent Pacemaker (PPM)

High-Risk ECG Alterations: New-onset Left Bundle Branch Block (LBBB) , 1st degree AV block paired with pre-existing RBBB, or complete high-degree AV block.

Pacemaker Requirement Rates: Occurs in 5–15% of balloon-expandable valves and 15–25% of self-expanding valves (due to deeper nitinol frame expansion into the left ventricular outflow tract [LVOT]).

Nursing Telemetry Standard: Continuous 12-lead ECG monitoring and telemetry tracking for at least 48 to 72 hours post-TAVR, with immediate availability of transcutaneous and temporary transvenous pacing.

Paravalvular Leak (PVL) Assessment

Paravalvular regurgitation occurs when incomplete sealing exists between the bioprosthetic valve frame and the asymmetric, heavily calcified native aortic annulus.

Diagnostic Assessment: Transthoracic/transesophageal Doppler echocardiography measuring jet width and circumferential extent.

Invasive Hemodynamic Index: Aortic Regurgitation Index (ARI) calculated during catheterization: ARI = [ DBP − LVEDP SBP ] × 100 \text{ARI} = \left[ \frac{\text{DBP} - \text{LVEDP}}{\text{SBP}} \right] \times 100 ARI = [ SBP DBP − LVEDP ​ ] × 100

An ARI < 25 indicates hemodynamically significant PVL, which correlates directly with accelerated hemolysis and increased 1-year mortality.

Large-Bore Vascular Access Bleeding

Post-procedural nursing monitoring must focus on large-bore femoral puncture sites:

Retroperitoneal Hemorrhage: Suspected when the patient exhibits unexplained hypotension, tachycardia, back/flank pain, or ipsilateral femoral neuropathy without visible groin bleeding. Obtain STAT abdominal/pelvic CT.

Groin Complications: Hematoma formation, pseudoaneurysm (pulsatile mass with audible bruit), and acute arterial thrombosis/limb ischemia (loss of pedal pulses).

Loading diagram... Structural Heart Interventions & Critical Nursing Management

Transcatheter Edge-to-Edge Repair (MitraClip / TEER)

Transcatheter Edge-to-Edge Repair (TEER) using the MitraClip system is indicated for severe symptomatic primary (degenerative) or secondary (functional) mitral regurgitation in patients determined to be at high surgical risk.

Transeptal Puncture & Procedural Steps

Femoral venous access is obtained, advancing a steerable guide catheter into the right atrium.

Transeptal Puncture: Under real-time transesophageal echocardiography (TEE) and fluoroscopy, a needle punctures the interatrial septum across the fossa ovalis to enter the left atrium.

The clip delivery system is maneuvered into the left ventricle, aligning the clip perpendicular to the mitral coaptation line. The mechanical arms grasp the anterior and posterior mitral valve leaflets together (creating a tissue bridge and a double-orifice mitral valve). Transeptal Puncture (RA ---> LA) ---> Mitral Valve Alignment ---> Grasp Anterior + Posterior Leaflets ---> Double-Orifice MV

Left Atrial Pressure (LAP) Monitoring & Waveform Signatures

Direct invasive left atrial pressure monitoring (or PCWP tracing) evaluates clip efficacy in real time:

Pre-Clipping Waveform: Characterized by a massive, prominent v-wave during late systole, created by regurgitant blood jetting backward into the non-compliant left atrium.

Post-Clipping Target: Successful clip placement produces an immediate, dramatic reduction in v-wave amplitude and a drop in mean LA pressure.

Mitral Gradient Safety Limit: Post-procedure mean mitral valve pressure gradient must remain < 5 mmHg . A mean gradient ≥ 5 mmHg indicates iatrogenic mitral stenosis, requiring clip adjustment prior to release.

Post-Procedure Nursing Management

Transeptal Site Monitoring: Monitor for an iatrogenic Atrial Septal Defect (ASD) with persistent left-to-right shunting, and monitor for pericardial effusion/tamponade resulting from accidental puncture of the LA free wall during transeptal access.

Post-Sheath Removal Care: Enforce flat bedrest for 4 to 6 hours post-venous sheath removal, and monitor telemetry for atrial fibrillation or supraventricular arrhythmias induced by atrial manipulation.

Pericardiocentesis & Post-Drainage Pulmonary Edema

Emergency pericardiocentesis is performed to evacuate fluid from the pericardial sac in patients presenting with cardiac tamponade (characterized by Beck's triad : hypotension, muffled heart sounds, and elevated CVP/jugular venous distension; along with pulsus paradoxus >10 mmHg ).

Guidance & Catheter Technique

Performed under real-time echocardiographic or fluoroscopic guidance.

Subxiphoid Approach: An 18-gauge spinal needle is inserted between the xiphoid process and left costal margin at a 30–45 degree angle, aiming toward the left shoulder. Alternatively, an apical approach is utilized.

A soft-tip guidewire is advanced, followed by a multi-holed pigtail drainage catheter secured to the skin.

Drainage Protocol & Re-accumulation Tracking

Connect the pigtail catheter to a closed gravity drainage bag.

Drainage Limit Rule: Avoid rapidly evacuating more than 500 to 1000 mL of pericardial fluid in a single initial bolus.

Catheter Maintenance: Record drainage volume, color (serous, sanguineous, purulent), and consistency every hour. The catheter is removed when 24-hour output drops below <25–50 mL .

Re-accumulation Monitoring: Sudden cessation of drainage accompanied by recurrent hypotension, surging CVP, or pulsus paradoxus indicates catheter occlusion by clot/fibrin or recurrent loculated tamponade.

Post-Drainage Pulmonary Edema (Pericardial Decompression Syndrome)

Post-pericardiocentesis pulmonary edema is a rare, life-threatening paradoxical complication that occurs immediately or hours after rapid drainage of a large, chronic pericardial effusion.

Pathophysiological Cascade:

Chronic pericardial tamponade suppresses both right and left ventricular end-diastolic volumes.

Evacuating the pericardial fluid suddenly removes external compressive forces. The thin-walled Right Ventricle recovers instantly , leading to a massive surge in RV venous return and RV stroke volume.

However, the thicker, non-compliant Left Ventricle remains transiently stunned and incapable of handling the sudden surge in blood volume returning from the lungs.

Blood backs up rapidly from the stunned LV into the left atrium and pulmonary capillaries, causing acute severe pulmonary capillary hypertension and fulminant cardiogenic pulmonary edema .

Prevention & Nursing Care: Limit initial pericardial fluid withdrawal to <500 mL, clamping the catheter if necessary to allow gradual hemodynamic re-equilibration. If edema develops, provide mechanical ventilation with PEEP, judicious inotropic support, and diuretics.

Structural Procedure Key Hemodynamic Target Primary Procedural Risk Essential AACN CMC Nursing Action

TAVR Aortic Regurgitation Index (ARI) > 25 New LBBB / Complete AV Block, Paravalvular Leak Continuous telemetry, PPM readiness, groin check for retroperitoneal bleed

MitraClip (TEER) Mean MV Gradient < 5 mmHg, V-wave reduction Accidental LA wall puncture, iatrogenic ASD, residual MR Monitor LAP tracings, monitor post-venous flat bedrest, echo for effusion

Pericardiocentesis Resolution of Beck's Triad and Pulsus Paradoxus Post-Drainage Pulmonary Edema, Cardiac Laceration Limit initial drainage to <500 mL, hourly output logs, monitor for LV stun